Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $219.04 Million |
|---|---|
| Enterprise Value | $219.97 Million |
| Earnings per Share | $0.19 |
| Beta | 0 |
| Outstanding Shares | 20,095,314 |
| P/E Ratio | 55.55 |
|---|---|
| PEG | -226.35 |
| Price to Sales | - |
| Price to Book Ratio | 1.82 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -83.53 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 36.15%▼ 23.38% |
|---|---|
| Total Invested | $71.71M▼ 42.58% |
| Investors Holding | 11▼ 12.00% |
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with...